Science Market Update

Texas A&M Awarded $9 M in Cancer Research Funding from CPRIT

Posted by Rebecca Inch-Partridge on Wed, Sep 26, 2018

The Cancer Prevention and Research Institute of Texas (CPRIT) awarded more than $9 million in research grants to Texas A&M University. Of the $9,057,870 in funding from CPRIT, more than $7.7 million is for academic research and $1.35 million is for a prevention grant. Eight grants were awarded by CPRIT. The largest was $5,793,075 to the recently established Center for Advanced Microscopy and Image Informatics (CAMII) in the Institute of Biosciences and Technology, College of Medicine.  

Read More

Tags: Texas A&M, Texas A&M Research, TAMU, Texas A&M Life Science Funding, Research equipment, biotech vendor show, Biotechnology Vendor Fair, BioResearch Product Faire, laboratory suppliers, cancer research grant, cancer researchers, colon cancer, medical marijuana

UC Davis: Major Cancer Research Funding Awarded by NCI

Posted by Rebecca Inch-Partridge on Thu, Sep 13, 2018

UC Davis Medical Center is home to one of only 49 National Cancer Institute (NCI) designated comprehensive cancer centers. The UC Davis Center is the only comprehensive cancer center in California’s Central Valley and inland northern California. It serves a region with a population of roughly 6 million people. The Center has $63 million in NHI and California Healthcare Institute funding.  

The NCI, a division of the NIH, awards University of California, Davis roughly $200 million annually to conduct cancer research.  

Here are the top 5 NCI grants this year:

Read More

Tags: CA, University of California Davis Medical Center, Southwest, UCDMC, BioResearch Product Faire Event, Sacramento, Oncology, Cancer Immunotherapy, Cancer Science, Comprehensive Cancer Center, cancer research funding, NIH funded Research Projects, biotech vendor show

University of Illinois Receives $2M for Herpes Virus Research

Posted by Rebecca Inch-Partridge on Fri, Aug 10, 2018

According to John Hopkins Medicine, 50 to 80 percent of U.S. adults have the oral herpes virus and many don’t know it. Most commonly associated with “cold sores” or “fever blister” the herpes virus can cause other, more serious symptoms as well. These include severe flu-like symptoms, swollen lymph nodes and headaches. The National Institutes of Health (NIH) recently awarded Afsar Naqvi, assistant professor at the University of Illinois, Chicago’s College of Dentistry, a five year, $2 million grant to study this wide spread and yet often misdiagnosed disease.

Read More

Tags: UIC, University of Illinois Chicago, biotech vendor show, Bioresearch, Bioresearch funding, UIChgo, Chicago, University of Illinois at Chicago, Illinois, University of Illinois, research news, BioResearch Product Faire, Cannabinoids, laboratory suppliers, laboratory equipment suppliers, virus research, Biologics, NIH funded Research Projects, NIH grants

University of Illinois Research News: Synthetic Cannabiniod Reduces Sleep Apnea

Posted by Rebecca Inch-Partridge on Thu, Jan 04, 2018

When obstructive sleep apnea (OSA) was listed as a contributing factor in the death of actress Carrie Fisher, it brought the condition into the spotlight. Until the news, many people considered sleep apnea to be just a bothersome form of snoring. However, with OSA, breathing is actually interrupted for a few seconds or even several minutes. According to the American sleep apnea association, 38,000 people die annually from heart disease directly complicated by sleep apnea. Now researchers at the University of Illinois, Chicago (UIC) believe they have found the first medication that reduces the effects of OSA, and it's  based on a molecule found in the cannabis plant.

Read More

Tags: UIC, University of Illinois Chicago, biotech vendor show, Bioresearch, Bioresearch funding, UIChgo, Chicago, University of Illinois at Chicago, Illinois, University of Illinois, research news, BioResearch Product Faire, Cannabinoids, cannabis research, clinical trials, laboratory suppliers, laboratory equipment suppliers

Washington University, St. Louis: $6 Million in Leukemia Research Funding

Posted by Rebecca Inch-Partridge on Thu, Dec 07, 2017

According to the National Cancer Institute (NCI) there are over 380,000 people living with leukemia in the United States. Each year roughly 24,500 people die from the disease and over 62,000 new cases are diagnosed. To improve treatment options for leukemia patients, the NCI recently awarded John DiPersio, MD, PhD of Washington University, St. Louis $6 million in research funding. The Professor of Medicine in Oncology at the university’s School of Medicine will use the seven years of funding to support three major areas of leukemia research in his lab. These include: improving the effectiveness of standard chemotherapy, preventing graft-versus-host disease, and developing new immunotherapies.

Read More

Tags: WUSTL, Washington University St. Louis, Washington University, Research Funding, Biotechnology trade show, biotech vendor show, Bioresearch Grant, WashU, Cancer, Leukemia, Cancer Immunotherapy, Cancer Therapeutics, cancer research, NIH awards 2017, cancer research funding

Biomedical News: Charlie’s Law Opens Opportunities for Stem Cell Treatments in Texas

Posted by Rebecca Inch-Partridge on Thu, Nov 02, 2017

In June, the Texas legislature unanimously passed Charlie’s Law which allows patients with chronic and terminal diseases access to experimental stem cell interventions. The law, named after the late Texas State representative Charlie Howard, is the first of its kind in the U.S.

Read More

Tags: Texas A&M, Texas A&M Research, TAMU, Texas A&M Life Science Funding, Research equipment, biotech vendor show, Biotechnology Vendor Fair, pollution, BioResearch Product Faire, laboratory suppliers, Texas Medical Center, tmc, Human Stem Cell, Stem cell research, Biomedical Reearch

Texas A&M: $10M in Research Funding to Study Effects of Harvey

Posted by Rebecca Inch-Partridge on Fri, Oct 13, 2017

In the aftermath of Hurricane Harvey, a group of researchers will study the effects of the pollution stirred up by the flooding. Scientists from Texas A&M, College Station will conduct four environmental research projects thanks to a five year, $10 million grant from the National Institute of Environmental Health Sciences (NIEHS) Superfund Research Program. All four projects will stem from a case study of Galveston Bay and the Houston Ship Channel that examines the chemicals found within the sediment. These studies are designed to improve our understanding of the complexities of hazardous chemicals exposure and its negative impacts on health.   

Read More

Tags: Texas A&M, Texas A&M Research, TAMU, Texas A&M Life Science Funding, Research equipment, biotech vendor show, Biotechnology Vendor Fair, environmental contaminants, pollution, BioResearch Product Faire, laboratory suppliers

UCLA: Utilizing Patient's Own Cells for Individualized Stem Cell Therapies

Posted by Rebecca Partridge on Wed, Feb 08, 2017

Researchers at UCLA believe using the patient’s own cells to create stem cells for therapeutic purposes is the future of medicine. A recently published study by scientists at UCLA demonstrates how specialized proteins change the cellular characteristics of skin cells to create induced pluripotent stem cells. These stem cells have the ability to turn into any cell type within the body. Also at UCLA, a clinical trial which uses the baby’s own blood-forming stem cells to treat the immune deficiency condition ADA-SCID, better known as “bubble baby disease,” was recently awarded a $20M grant from the California Institute for Regenerative Medicine.

Read More

Tags: UCLA, University of California Los Angeles, Stem Cell, Human Stem Cell, Stem cell research, Biotechnology trade show, biotech vendor show

Washington University, St. Louis Leading Drug Trial for Alzheimer's Prevention

Posted by Rebecca Partridge on Tue, Jan 24, 2017

Washington University School of Medicine in St. Louis is leading an international team studying potential treatments to prevent Alzheimer’s disease. The team recently added a third medicationin this worldwide clinical trial that is already underway. According to the WU School of Medicine news site, the latest investigational drug “is designed to lower production of amyloid beta, a protein that clumps together into plaques damaging neurons in the brain, leading to memory loss, cognitive problems and confusion.”

Read More

Tags: WUSTL, Washington University St. Louis, Washington University, Alzheimer' Research, Alzheimer’s, Alzheimer's treatment market, Research Funding, Biotechnology trade show, biotech vendor show, Bioresearch Grant

Two New Mass Spectrometers Make Texas A&M a Top Facility for Studying Isotopes

Posted by Rebecca Partridge on Thu, Jan 19, 2017

The chancellor’s office of Texas A&M University (TAMU) recently funded a $5 million initiative to support mass spectrometry research. As part of this initiative a $1 million grant from the Texas A&M University Research Development Fund will be used to develop a shared mass spectrometry core facility and buy two new mass spectrometers for the College Station campus. One will be a gas chromatography combustion/pyrolysis isotope ratio mass spectrometer and the other will be a high resolution isotope ratio mass spectrometer for clumped isotopes.

Read More

Tags: Texas A&M, Texas A&M Research, TAMU, Texas A&M Life Science Funding, Research equipment, biotech vendor show, Biotechnology Vendor Fair

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News